Korey Hood

Korey K. Hood, PhD, Professor, Departments of Endocrinology and Diabetes and Psychiatry & Behavioral Sciences, Stanford University School of Medicine

Research Description:  Dr. Hood is a licensed clinical psychologist and is part of the diabetes care team at Stanford. He is the past chair of the American Diabetes Association’s Behavioral Medicine and Psychology Interest Group and is current chair of the ADA special interest group on behavioral medicine and member of the research policy committee. Dr. Hood’s research program over the past 13 years has made important contributions to the understanding of psychosocial aspects of diabetes management, and how these factors contribute to disease outcomes. There are two content threads to his work: 1) construct prevention and treatment programs to address modifiable psychological and family factors that create barriers to optimal diabetes management, and 2) optimize the use of devices and technologies to improve outcomes. Dr. Hood’s group collaborates locally and nationally with multiple NIDDK funded investigators and has advanced expertise in study design, methodology, and statistics. Dr. Hood is also co-leader of the Bioengineering & Behavioral Sciences Research Affinity Group in SDRC, and serves on the SDRC Executive Committee.

Selected relevant publications (Stanford DRC members in BOLD):

  1. Tanenbaum ML, Zaharieva DP, Addala A, Ngo J, Prahalad P, Leverenz B, New C, Maahs DM, Hood KK. "I was ready for it at the beginning": Parent experiences with early introduction of continuous glucose monitoring following their child's Type 1 diabetes diagnosis. Diabet Med. 2021 Mar 27:e14567. doi: 10.1111/dme.14567. PMID: 33772862. 

  2. Lanning MS, Tanenbaum ML, Wong JJ, Hood KK. Barriers to Continuous Glucose Monitoring in People With Type 1 Diabetes: Clinician Perspectives. Diabetes Spectr. 2020 Nov;33(4):324-330. doi: 10.2337/ds19-0039. PMID: 33223770; PMCID: PMC7666603. 

  3. Prahalad P, Addala A, Scheinker D, Hood KK, Maahs DM. CGM Initiation Soon After Type 1 Diabetes Diagnosis Results in Sustained CGM Use and Wear Time. Diabetes Care. 2020 Jan;43(1):e3-e4. doi: 10.2337/dc19-1205. PMID: 31558548; PMCID: PMC7011198. 

  4. Hirsch IB, Sherr JL, Hood KK. Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes. Diabetes Care. 2019 Mar;42(3):345-348. doi: 10.2337/dci18-0040. PMID: 30787056; PMCID: PMC6973546. 

  5. Varni JW, Delamater AM, Hood KK, Driscoll KA, Wong JC, Adi S, Yi-Frazier JP, Grishman EK, Faith MA, Corathers SD, Kichler JC, Miller JL, Raymond JK, Doskey EM, Aguirre V, Heffer RW, Wilson DP; Pediatric Quality of Life Inventory 3.2 Diabetes Module Testing Study Consortium. Diabetes management mediating effects between diabetes symptoms and health-related quality of life in adolescents and young adults with type 1 diabetes. Pediatr Diabetes. 2018 Nov;19(7):1322-1330. doi: 10.1111/pedi.12713. PMID: 29927039; PMCID: PMC6641859. 

  6. Iturralde E, Adams RN, Barley RC, Bensen R, Christofferson M, Hanes SJ, Maahs DM, Milla C, Naranjo D, Shah AC, Tanenbaum ML, Veeravalli S, Park KT, Hood KK. Implementation of Depression Screening and Global Health Assessment in Pediatric Subspecialty Clinics. J Adolesc Health. 2017 Nov;61(5):591-598. doi: 10.1016/j.jadohealth.2017.05.030. PMID: 28830798; PMCID: PMC7162556.